Observational studyCardiovascular diabetology2021

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study.

Moa Lugner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.